| Nucala 100 mg solution for injection in pre-filled pen EU/1/15/1043/003-004 |
Mepolizumab |
GlaxoSmithKline Trading Services Limited |
— |
| Nucala 100 mg solution for injection in pre-filled syringe EU/1/15/1043/005-006 |
Mepolizumab |
GlaxoSmithKline Trading Services Limited |
— |
| Nucala 40 mg solution for injection in pre-filled syringe EU/1/15/1043/009-010 |
Mepolizumab |
GlaxoSmithKline Trading Services Limited |
— |
| Nuceiva 100 U Powder for solution for injection EU/1/19/1364/001 |
Botulinum Toxin Type A |
Evolus Pharma Ltd. |
— |
| Nuceiva 50 U Powder for solution for injection EU/1/19/1364/002 |
Botulinum Toxin Type A |
Evolus Pharma Ltd. |
— |
| NULIBRY 9.5 mg powder for solution for injection EU/1/22/1684/001 |
Fosdenopterin hydrobromide dihydrate |
TMC Pharma (EU) Limited |
— |
| NULOJIX 250 mg powder for concentrate for solution for infusion EU/1/11/694/001-002 |
Belatacept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Nurofen Cold & Flu film-coated tablets Ibuprofen 200mg Pseudoephedrine hydrochloride 30mg PPA0465/337/002 |
Ibuprofen, PSEUDOEPHEDRINE HYDROCHLORIDE |
PCO Manufacturing Ltd. |
— |
| Nurofen Cold & Flu Film-coated Tablets Ibuprofen 200mg Pseudophedrine hydrochloride 30mg PA0979/033/001 |
Ibuprofen, PSEUDOEPHEDRINE HYDROCHLORIDE |
Reckitt Benckiser Ireland Limited |
Marketed |
| Nurofen Sinus and Pain Film-Coated Tablets Ibuprofen 200mg Pseudoephedrine Hydrochloride 30mg PA0979/065/001 |
Ibuprofen, PSEUDOEPHEDRINE HYDROCHLORIDE |
Reckitt Benckiser Ireland Limited |
Marketed |
| Nustendi 180 mg/10 mg film-coated tablets EU/1/20/1424/001-006 |
Bempedoic Acid |
Daiichi Sankyo Europe GmbH |
— |
| Nutriflex basal solution for infusion PA0736/005/001 |
Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine |
B. Braun Melsungen AG |
Not marketed |
| Nutriflex peri solution for infusion PA0736/006/001 |
Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine |
B. Braun Melsungen AG |
Not marketed |
| Nutriflex plus solution for infusion PA0736/007/001 |
Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine |
B. Braun Melsungen AG |
Not marketed |
| Nutriflex special solution for infusion PA0736/008/001 |
Isoleucine, Leucine, Lysine hydrochloride, Methionine, Phenylalanine |
B. Braun Melsungen AG |
Not marketed |
| NutropinAq 10 mg/2 ml solution for injection EU/1/00/164/003-004 |
Somatropin |
Ipsen Pharma |
— |
| NutropinAq 10 mg/2 ml solution for injection EU/1/00/164/005 |
Somatropin |
Ipsen Pharma |
— |
| Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) EU/1/21/1618/001 |
SARS-CoV-2 spike protein recombinant |
Sanofi Winthrop Industrie |
— |
| Nuwiq 1000 IU powder and solvent for solution for injection EU/1/14/936/003 |
Simoctocog alfa |
Octapharma AB |
— |
| Nuwiq 1500 IU powder and solvent for solution for injection EU/1/14/936/008 |
Simoctocog alfa |
Octapharma AB |
— |
| Nuwiq 2000 IU powder and solvent for solution for injection EU/1/14/936/004 |
Simoctocog alfa |
Octapharma AB |
— |
| Nuwiq 250 IU powder and solvent for solution for injection EU/1/14/936/001 |
Simoctocog alfa |
Octapharma AB |
— |
| Nuwiq 2500 IU powder and solvent for solution for injection EU/1/14/936/005 |
Simoctocog alfa |
Octapharma AB |
— |
| Nuwiq 3000 IU powder and solvent for solution for injection EU/1/14/936/006 |
Simoctocog alfa |
Octapharma AB |
— |
| Nuwiq 4000 IU powder and solvent for solution for injection EU/1/14/936/007 |
Simoctocog alfa |
Octapharma AB |
— |
| Nuwiq 500 IU powder and solvent for solution for injection EU/1/14/936/002 |
Simoctocog alfa |
Octapharma AB |
— |
| Nyvepria 6 mg solution for injection EU/1/20/1486/001 |
Pegfilgrastim |
Pfizer Europe MA EEIG |
— |
| Nyxoid 1.8 mg Nasal spray, solution EU/1/17/1238/001 |
Naloxone hydrochloride dihydrate |
Mundipharma Corporation (Ireland) Limited |
— |
| Obgemsa 75 mg film-coated tablets EU/1/24/1822/001-006 |
Vibegron |
Pierre Fabre Medicament |
— |
| OBIZUR 500 U powder and solvent for solution for injection EU/1/15/1035/001-003 |
Susoctocog alfa |
Baxter Innovations GmbH |
— |
| Obodence 60 mg solution for injection in pre-filled syringe EU/1/24/1890/001 |
Denosumab |
Samsung Bioepis NL B.V. |
— |
| Ocaliva EU/1/16/1139/001 |
Obeticholic acid |
Advanz Pharma Limited |
— |
| Ocaliva EU/1/16/1139/002 |
Obeticholic acid |
Advanz Pharma Limited |
— |
| Ocrevus 300 mg concentrate for solution for infusion EU/1/17/1231/001-002 |
Ocrelizumab |
Roche Registration GmbH |
— |
| Ocrevus 920 mg solution for injection EU/1/17/1231/003 |
Ocrelizumab |
Roche Registration GmbH |
— |
| Octreoscan 111 MBq/mL, kit for radiopharmaceutical preparation PA0690/001/001 |
Indium (111 in) chloride solution, Pentetreotide |
Curium Netherlands B.V. |
Marketed |
| Oczyesa 20 mg prolonged-release solution for injection in pre-filled pen EU/1/25/1938/001 |
Octreotide hydrochloride |
Camurus AB |
— |
| Odefsey 200 mg/25 mg/25 mg film-coated tablets EU/1/16/1112/001-002 |
Emtricitabine, Rilpivirine, Tenofovir alafenamide |
Gilead Sciences Ireland UC |
— |
| Odomzo 200 mg hard capsules EU/1/15/1030/001-002 |
Sonidegib |
Sun Pharmaceutical Industries Europe B.V. |
— |
| Ofev 100 mg Soft capsule EU/1/14/979/001-002 |
Nintedanib |
Boehringer Ingelheim International GmbH |
— |
| Ofev 150 mg Soft capsule EU/1/14/979/003-004 |
Nintedanib |
Boehringer Ingelheim International GmbH |
— |
| Ofev 25mg Soft capsule EU/1/14/979/009-012 |
Nintedanib esylate |
Boehringer Ingelheim International GmbH |
— |
| Ogivri 150 mg powder for concentrate for solution for infusion EU/1/18/1341/001 |
Trastuzumab |
Biosimilar Collaborations Ireland Limited |
— |
| Ogivri 420 mg powder for concentrate for solution for infusion EU/1/18/1341/002 |
Trastuzumab |
Biosimilar Collaborations Ireland Limited |
— |
| Ogluo 0.5 mg solution for injection in pre-filled pen EU/1/20/1523/001-002 |
GLUCAGON |
Strongbridge Dublin Limited |
— |
| Ogluo 0.5 mg solution for injection in pre-filled syringe EU/1/20/1523/003-004 |
GLUCAGON |
Strongbridge Dublin Limited |
— |
| Ogluo 1 mg solution for injection in pre-filled pen EU/1/20/1523/005-006 |
GLUCAGON |
Strongbridge Dublin Limited |
— |
| Ogluo 1 mg solution for injection in pre-filled syringe EU/1/20/1523/007-008 |
GLUCAGON |
Strongbridge Dublin Limited |
— |
| Ogsiveo 100 mg film‑coated tablets EU/1/25/1932/003 |
Nirogacestat hydrobromide |
Springworks Therapeutics Ireland Limited |
— |
| Ogsiveo 150 mg film‑coated tablets EU/1/25/1932/004 |
Nirogacestat hydrobromide |
Springworks Therapeutics Ireland Limited |
— |